The Menopause Digital Hormone Balancing App market size is expected to reach $3.35 billion in 2030 at 17%, driven by rising smartphone penetration.
Read MoreGlobal Menopause market size is expected to reach $26.21 billion by 2030 at 7.1%, segmented as by dietary supplements, herbal supplements, vitamins and minerals, phytoestrogens, omega-3 fatty acids, probiotics
Read MoreGlobal Menopausal Hot Flashes market size is expected to reach $21.68 billion by 2030 at 6.5%, government-led menopausal health initiatives is a catalyst for growth in the menopausal hot flashes market
Read MoreGlobal Meningococcal Disease Vaccine market size is expected to reach $4.11 by 2030 at 9.6%, government immunization programs fueling the growth of the market due to increasing access awareness and mandates
Read MoreThe melatonin market is projected to reach $2.99 billion by 2030, growing at 7.9% CAGR, driven by personalized sleep solutions, natural supplements, and mental wellness focus.
Read MoreThe meibomian gland dysfunction market is projected to reach $6.12 billion by 2030, growing at 6.6% CAGR, driven by device-assisted therapies, home-use treatments, and personalized eye care.
Read MoreGlobal Medications For Heart Failure market size is expected to reach $15.03 by 2030 at 6.8%, the rising prevalence of cardiovascular diseases fueling the growth of the market due to increasing demand for effective heart failure treatments
Read MoreMedication side-effect tracker app market to reach $2.79 billion by 2030 at 14% CAGR, driven by growing adoption of patient-centric healthcare solutions.
Read MoreGlobal Medication Management System market size is expected to reach $10.34 billion by 2030 at 18.8%, segmented as by product type, computerized physician order entry, clinical decision support system solutions
Read MoreThe medication adherence market is projected to reach $7.35 billion by 2030, growing at 11.4% CAGR, driven by remote monitoring, smart devices, telehealth, and patient engagement solutions.
Read More